These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 34496544)
1. [Identification of serum biomarkers and evaluation of metabolism disorders in patients with oral squamous cell carcinoma]. Li XB; Liu LW; Li N; Jia QQ; Wang XS; Long JL; Xue P; Sun Z; Zhao HY Zhonghua Kou Qiang Yi Xue Za Zhi; 2021 Sep; 56(9):926-932. PubMed ID: 34496544 [No Abstract] [Full Text] [Related]
2. Metabolomics based plasma biomarkers for diagnosis of oral squamous cell carcinoma and oral erosive lichen planus. Li X; Liu L; Li N; Jia Q; Wang X; Zuo L; Long J; Xue P; Sun Z; Zhao H J Cancer; 2022; 13(1):76-87. PubMed ID: 34976172 [No Abstract] [Full Text] [Related]
3. [Study of salivary metabonomics in patients with oral squamous cell carcinoma and leukoplakia]. Xue JY; Zhu XY; Wei CL; Sun P; Zhang H; Deng J Shanghai Kou Qiang Yi Xue; 2021 Apr; 30(2):201-205. PubMed ID: 34109363 [TBL] [Abstract][Full Text] [Related]
4. [Risk prediction of metabolic syndrome and coronary artery disease in overweight and obese populations based on serum metabolomics]. Pei JY; Zhang DD; He H; Zheng LL; Du SZ; Jing ZW Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Dec; 51(12):1247-1255. PubMed ID: 38123207 [No Abstract] [Full Text] [Related]
5. Assessment of serum synuclein-γ and squamous cell carcinoma antigen as diagnostic biomarkers in patients with oral squamous cell carcinoma and oral potentially malignant disorders. Chen L; Luo T; Yang J; Wang K; Liu S; Wei Y; Liu H; Xu J; Zheng J; Zeng Y J Oral Pathol Med; 2021 Feb; 50(2):165-174. PubMed ID: 33064859 [TBL] [Abstract][Full Text] [Related]
6. Detection of serum/salivary exosomal Alix in patients with oral squamous cell carcinoma. Nakamichi E; Sakakura H; Mii S; Yamamoto N; Hibi H; Asai M; Takahashi M Oral Dis; 2021 Apr; 27(3):439-447. PubMed ID: 32688445 [TBL] [Abstract][Full Text] [Related]
7. Identification of salivary metabolites for oral squamous cell carcinoma and oral epithelial dysplasia screening from persistent suspicious oral mucosal lesions. Ishikawa S; Wong DTW; Sugimoto M; Gleber-Netto FO; Li F; Tu M; Zhang Y; Akin D; Iino M Clin Oral Investig; 2019 Sep; 23(9):3557-3563. PubMed ID: 30539290 [TBL] [Abstract][Full Text] [Related]
8. Label-free plasma proteomics for the identification of the putative biomarkers of oral squamous cell carcinoma. Gautam SS; Singh RP; Karsauliya K; Sonker AK; Reddy PJ; Mehrotra D; Gupta S; Singh S; Kumar R; Singh SP J Proteomics; 2022 May; 259():104541. PubMed ID: 35231661 [TBL] [Abstract][Full Text] [Related]
9. Discrimination of oral squamous cell carcinoma from oral lichen planus by salivary metabolomics. Ishikawa S; Sugimoto M; Edamatsu K; Sugano A; Kitabatake K; Iino M Oral Dis; 2020 Jan; 26(1):35-42. PubMed ID: 31602722 [TBL] [Abstract][Full Text] [Related]
10. Quantitative Proteomic Analysis of Non-Tobacco Associated Oral Squamous Cell Carcinoma Reveals Deregulation of Cytoskeletal and Apoptotic Proteins. T A S; Narayan M; Krishnan R; Thayalan D; Gunasekaran N; S P Asian Pac J Cancer Prev; 2022 Dec; 23(12):4285-4292. PubMed ID: 36580011 [TBL] [Abstract][Full Text] [Related]
11. Investigation and identification of potential biomarkers in human saliva for the early diagnosis of oral squamous cell carcinoma. Wang Q; Gao P; Wang X; Duan Y Clin Chim Acta; 2014 Jan; 427():79-85. PubMed ID: 24144867 [TBL] [Abstract][Full Text] [Related]
12. Detection of peripheral blood circulating tumor cells in oral squamous cell carcinoma and its clinical significance. Zhang SY; Qin S; Li GH; Yi YQ; Fu HJ; Gao YJ; Sun ML Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Oct; 39(5):591-597. PubMed ID: 34636209 [TBL] [Abstract][Full Text] [Related]
13. Exploring a Novel Screening Method for Patients with Oral Squamous Cell Carcinoma: A plasma Metabolomics Analysis. Enomoto Y; Kimoto A; Suzuki H; Nishiumi S; Yoshida M; Komori T Kobe J Med Sci; 2018 Sep; 64(1):E26-E35. PubMed ID: 30282895 [TBL] [Abstract][Full Text] [Related]
14. Application of metabolomics in oral squamous cell carcinoma. Luo G; Wang S; Lu W; Ju W; Li J; Tan X; Zhao H; Han W; Yang X Oral Dis; 2024 Sep; 30(6):3719-3731. PubMed ID: 38376209 [TBL] [Abstract][Full Text] [Related]
15. Oral squamous cell carcinoma patients can be differentiated from healthy individuals with label-free serum proteomics. Saraswat M; Mäkitie A; Agarwal R; Joenväärä S; Renkonen S Br J Cancer; 2017 Jul; 117(3):376-384. PubMed ID: 28632724 [TBL] [Abstract][Full Text] [Related]
16. Analysis of metabolomics and transcriptomics data in head and neck squamous cell carcinoma. Li W; Li Y; Chen Z; Lam AK; Li Z; Liu X; Zhu B; Qiao B Oral Dis; 2023 May; 29(4):1464-1479. PubMed ID: 34990052 [TBL] [Abstract][Full Text] [Related]
17. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma. Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475 [TBL] [Abstract][Full Text] [Related]
18. Blood and Salivary MicroRNAs for Diagnosis of Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis. Liu D; Xin Z; Guo S; Li S; Cheng J; Jiang H J Oral Maxillofac Surg; 2021 May; 79(5):1082.e1-1082.e13. PubMed ID: 33516682 [TBL] [Abstract][Full Text] [Related]
19. Corneodesmosin as a potential target of oral squamous cell carcinoma. Di YB; Bao Y; Guo J; Liu W; Zhang SX; Zhang GH; Li TK Medicine (Baltimore); 2022 Sep; 101(39):e28397. PubMed ID: 36181011 [TBL] [Abstract][Full Text] [Related]
20. Serum metabolomics in oral leukoplakia and oral squamous cell carcinoma. Sridharan G; Ramani P; Patankar S J Cancer Res Ther; 2017; 13(3):556-561. PubMed ID: 28862226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]